DESITIN PHARMA A/S: Financial statements 2025
CVR: 19389006
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. That is an increase of 1.4% compared with the year before. Equity in the 2025 report amounted to DKK 7,044,140. The solvency ratio was 91.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,151,761
- Profit/Loss
- DKK 288,733
- Equity
- DKK 7,044,140
- Total Assets
- DKK 7,712,168
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.2M | 289K | 7M | 2 |
| 2024 | - | 2.1M | 286K | 6.8M | 2 |
| 2023 | - | 3M | 2.6M | 8.6M | 2 |
| 2022 | - | 3.5M | 346K | 6.4M | 2 |
| 2021 | - | 3.8M | 353K | 6.4M | 2 |
Official annual report
How creditworthy is DESITIN PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
DESITIN PHARMA A/S has won the tender "Amgros 2026 1.615.b" issued by Amgros I/S worth 48,195,968 DKK.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 3,230,179 and a net result of DKK 350,332 compared with DKK 288,733 the year before. Equity in the 2026 report amounted to DKK 7,394,472.